Is Britain becoming the sick man of Europe again?
Crisis or just bad headlines? In this special guest episode, Marc sits down with Cerys Mitchell, Tom Padgett and Geraint Roberts. Is the UK healthcare system declining, or just under pressure? We separate perception from reality.
What ISPOR 2026 is telling us about the future of health economics – AI in healthcare
AI was everywhere at ISPOR 2026, but the conversation has matured well past the hype. In this final episode of the series, Phil and Marc look at where agentic AI and large language models are genuinely changing HEOR practice — from AI-assisted systematic literature reviews to frameworks for evaluating AI use in submissions. They also […]
What ISPOR 2026 is telling us about the future of health economics – value in healthcare in 2026
What does “value” mean in healthcare in 2026? This episode tracks a theme running through ISPOR sessions all week: the limitations of the QALY as the dominant currency of cost-effectiveness, and the methods, distributional cost-effectiveness analysis among them, being developed to better capture equity. Phil, Marc and guest Hamzah Aideed also bring it home to […]
What ISPOR 2026 is telling us about the future of health economics – the challenge of real world evidence
Real-world evidence has moved from a supplementary nice-to-have to a central plank of HTA submissions — but with that shift comes a harder set of questions. In this episode, Phil, Marc and Hamzah Aideed look at what ISPOR 2026 revealed about the state of RWE: the push to use unconventional data sources, including patient-reported and […]
What ISPOR 2026 is telling us about the future of health economics – the global impact of US health policy
In this opening episode of our ISPOR 2026 debrief series, Phil McEwan and Hamzah Aideed unpack the policy story dominating Philadelphia this year: how the US is moving to reshape drug pricing, and what that means for the rest of the world. From the Most Favoured Nation pricing strategy to ongoing Medicare negotiations under the […]
You built the model. Now what?
A model is only useful if people understand it. So how do you turn complex outputs into real-world decisions?
What model do I use and why?
From simple equations to complex simulations how to choose the tools that shape healthcare policy.
What is a model? And when is it wrong?
Models simplify reality but at what cost? We break down their strengths, limits, and risks.
The models behind billion-pound decisions
Health economic models shape billion pound decisions but how do they actually work? This episode breaks down the fundamentals in a clear, practical way.
Why we know the solutions to health inequality, but don’t act
We already know how to reduce health inequalities, so why hasn’t it happened? This episode explores the gap between evidence and action.